Because of spam, I personally moderate all comments left on my blog. However, because of health issues, I will not be able to do so in the future.

If you have a personal question about LI or any related topic you can send me an email at I will try to respond.

Otherwise, this blog is now a legacy site, meaning that I am not updating it any longer. The basic information about LI is still sound. However, product information and weblinks may be out of date.

In addition, my old website, Planet Lactose, has been taken down because of the age of the information. Unfortunately, that means links to the site on this blog will no longer work.

For quick offline reference, you can purchase Planet Lactose: The Best of the Blog as an ebook on or Almost 100,000 words on LI, allergies, milk products, milk-free products, and the genetics of intolerance, along with large helpings of the weirdness that is the Net.

Friday, August 22, 2008

Baby Bottles Still Safe FDA Says

Only a tiny minority of infants never go through a bottle-feeding stage, even if they were breastfed during their first few months of life. Many of my readers are parents whose children have such severe allergies that they must always be bottle-bed.

News that baby bottles themselves might have a harmful contaminant would shake the entire population of parents with very young children.

The FDA took steps this week to try to quiet those fears, concerning a chemical named Bisphenol A (BPA).

FDA has been reviewing the emerging literature on BPA on a continuous basis. For example, FDA has recently completed a review of the available biological fate data and two recently completed rodent multigeneration reproductive studies; these studies did not indicate a safety concern for BPA at current exposure levels. In addition, FDA is conducting a review of the data on neural and behavioral effects of BPA exposure.

Based on our ongoing review, we believe there is a large body of evidence that indicates that FDA-regulated products containing BPA currently on the market are safe and that exposure levels to BPA from food contact materials, including for infants and children, are below those that may cause health effects. However, we will continue to consider new research and information as they become available.

This position is consistent with two risk assessments for BPA conducted by the European Food Safety Authority (EFSA) Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food and the Japanese National Institute of Advanced Industrial Science and Technology. Each of these documents considered the question of a possible low-dose effect and concluded that no current health risk exists for BPA at the current exposure level.

For those who continue to have worries, the FDA also added this:
Message for Consumers
At this time, FDA is not recommending that anyone discontinue using products that contain BPA while we continue our risk assessment process. However, concerned consumers should know that several alternatives to polycarbonate baby bottles exist, including glass baby bottles.

You should know that you almost certainly have traces of BPA in your body, in extremely low levels. The Associated Press reported:
About 93 percent of Americans have traces of bisphenol in their urine, according to the Centers for Disease Control and Prevention.

But the F.D.A.’s report concluded that those levels were thousands of times below what would actually be dangerous to adults or children.

Some consumer groups naturally claim that any levels of this chemical is harmful. However, that's not what the current research suggests. If you do want to avoid it nevertheless, then glass bottles are the best choice.

Bookmark and Share

1 comment:

Anonymous said...

Congress Threatens FDA With Subpoenas for Information on Approval of Infant Formula Contaminant

In a letter to FDA Commissioner Andrew von Eschenbach, MD, Reps. John Dingell (D-MI) and Bart Stupak (D-MI) ­ the House Energy and Commerce Committee chair and its Investigations Subcommittee chair, demanded FDA provide information on why it ignored voluminous independent, peer-reviewed studies finding cause for concern over exposure to BPA, and instead used just two reports funded by the plastics industry when it claimed the chemical posed no risk to infants. '… it appears that the Food and Drug Administration's (FDA) position on BPA's safety is entirely dependent on two studies, both of which are funded by the American Plastics Council, and one of which has not been published or peer-reviewed. Given that there are dozens of published, peer-reviewed studies related to BPA, your development of critical public health policy in this manner, especially as related to infants and children, seems highly questionable,' wrote the lawmakers.

The full text of the Dingell/Stupak Letter to Commissioner von Eschenbach can be found at the Committee's website